Impact of the first nirsevimab immunization campaign on infant RSV-related emergency department visits and hospitalizations in Québec, Canada.
- DOI
- 10.1097/ede.0000000000002050
- Published
- 2026 Sep 15
- Container
- Epidemiology (Cambridge, Mass.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/ede.0000000000002050,
title = {Impact of the first nirsevimab immunization campaign on infant RSV-related emergency department visits and hospitalizations in Québec, Canada.},
author = {Bemmo A and Fortin É and Fortin P and Doggui R and Guay CA and Amini R and Carazo S and Papenburg J and Gilca R},
year = {2026},
journal = {Epidemiology (Cambridge, Mass.)},
doi = {10.1097/ede.0000000000002050},
url = {https://doi.org/10.1097/ede.0000000000002050}
}RIS
TY - JOUR TI - Impact of the first nirsevimab immunization campaign on infant RSV-related emergency department visits and hospitalizations in Québec, Canada. AU - Bemmo A AU - Fortin É AU - Fortin P AU - Doggui R AU - Guay CA AU - Amini R AU - Carazo S AU - Papenburg J AU - Gilca R PY - 2026 JO - Epidemiology (Cambridge, Mass.) DO - 10.1097/ede.0000000000002050 UR - https://doi.org/10.1097/ede.0000000000002050 ER -
APA
A, B., É, F., P, F., R, D., CA, G., R, A., S, C., J, P., & R, G. (2026). Impact of the first nirsevimab immunization campaign on infant RSV-related emergency department visits and hospitalizations in Québec, Canada.. Epidemiology (Cambridge, Mass.). https://doi.org/10.1097/ede.0000000000002050
Source records
- pubmed · retrieved 2026-09-26T08:56:55.422Z